Iqvia Holdings (IQV) Current Deferred Revenue (2012 - 2026)
Iqvia Holdings (IQV) posted Current Deferred Revenue of $2.3 billion for Q2 2026, up 0.88% sequentially from $2.3 billion in Q1 2026, and up 7.44% YoY from $2.1 billion in Q2 2025.
Iqvia Holdings (IQV) Current Deferred Revenue (2012 - 2026) Analysis & Trends
Iqvia Holdings has reported Current Deferred Revenue for 15 years, with the latest figure at $2.3 billion in Q2 2026.
- Quarterly Current Deferred Revenue rose 7.44% year-over-year to $2.3 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $2.3 billion (up 7.44% YoY) and the FY2025 annual result came in at $2.1 billion, up 19.06% from the prior year.
- Current Deferred Revenue improved to $2.3 billion in Q2 2026 per IQV's latest filing, from $2.3 billion in the prior quarter.
- Over five years, Current Deferred Revenue peaked at $2.3 billion in Q2 2026 and troughed at $1.8 billion in Q4 2024.
- A 5-year average of $1.9 billion and a median of $1.8 billion in 2022 frame the typical range for Current Deferred Revenue.
- The sharpest annual moves came in 2022 and 2023: Current Deferred Revenue grew 24.0% in 2022, then retreated 5.19% in 2023.
- Over 5 years, Current Deferred Revenue stood at $1.8 billion in 2022, then advanced by 0.11% to $1.8 billion in 2023, then fell by 1.11% to $1.8 billion in 2024, then rose by 19.06% to $2.1 billion in 2025, then gained by 7.7% to $2.3 billion in 2026.
- According to Business Quant data, Current Deferred Revenue over the past three periods registered $2.3 billion, $2.3 billion, and $2.1 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 214.22 Bn | 210.16 Bn | 8.34 Bn |
| 2 | Danaher | 140.38 Bn | 136.03 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.15 Bn | 45.95 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.80 Bn | 37.99 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.51 Bn | 37.43 Bn | 1.44 Bn |
| 6 | Natera | 38.83 Bn | 37.73 Bn | 696.04 Mn |
| 7 | Illumina | 30.02 Bn | 28.85 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.64 Bn | 28.59 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.17 Bn | 25.54 Bn | 1.03 Bn |
| 10 | Labcorp Holdings | 25.90 Bn | 24.92 Bn | 1.01 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.28 Bn |
| Mar 31, 2026 | 2.26 Bn |
| Dec 31, 2025 | 2.12 Bn |
| Sep 30, 2025 | 2.16 Bn |
| Jun 30, 2025 | 2.12 Bn |
| Mar 31, 2025 | 1.94 Bn |
| Dec 31, 2024 | 1.78 Bn |
| Sep 30, 2024 | 1.82 Bn |
| Jun 30, 2024 | 1.81 Bn |
| Mar 31, 2024 | 1.91 Bn |
| Dec 31, 2023 | 1.80 Bn |
| Sep 30, 2023 | 1.84 Bn |
| Jun 30, 2023 | 1.84 Bn |
| Mar 31, 2023 | 1.83 Bn |
| Dec 31, 2022 | 1.80 Bn |
| Sep 30, 2022 | 1.84 Bn |
| Jun 30, 2022 | 1.81 Bn |
| Mar 31, 2022 | 1.93 Bn |
| Dec 31, 2021 | 1.83 Bn |
| Sep 30, 2021 | 1.83 Bn |